Technetium (99mTc) medronic acid
Technetium (99mTc) medronic acid is a radiopharmaceutical used primarily in nuclear medicine for bone imaging. It is a compound that combines technetium-99m (99mTc), a widely used radioisotope, with medronic acid, a phosphonate compound that targets bone tissue.
Mechanism of Action[edit | edit source]
Technetium (99mTc) medronic acid works by binding to the hydroxyapatite crystals in bone. The technetium-99m emits gamma radiation, which can be detected by a gamma camera. This allows for the visualization of bone structure and the identification of abnormalities such as bone metastases, fractures, and osteomyelitis.
Clinical Use[edit | edit source]
Technetium (99mTc) medronic acid is used in bone scintigraphy, a diagnostic imaging technique. It is particularly useful for detecting bone metastases in patients with cancer, evaluating unexplained bone pain, and diagnosing osteomyelitis.
Administration[edit | edit source]
The compound is administered intravenously. After injection, it typically takes about 2-4 hours for optimal imaging, as the radiopharmaceutical accumulates in the bone tissue.
Safety and Side Effects[edit | edit source]
Technetium (99mTc) medronic acid is generally well-tolerated. However, potential side effects include allergic reactions, injection site reactions, and, rarely, radiation exposure risks. It is contraindicated in patients with known hypersensitivity to any component of the formulation.
Related Pages[edit | edit source]
Categories[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD